Regnante Keith (CIK 1682068) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-20). Recent activity: Sell KROS (4,739 shares), Buy KROS (44,000 shares), Buy KROS (40,000 shares), Sell KROS (40,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-20 | Keros Therapeutics, Inc. (KROS) | CHIEF FINANCIAL OFFICER | Sell | 4,739 | $77,483 |
| 2025-02-19 | Keros Therapeutics, Inc. (KROS) | CHIEF FINANCIAL OFFICER | Buy | 44,000 | $0 |
| 2025-01-24 | Keros Therapeutics, Inc. (KROS) | CHIEF FINANCIAL OFFICER | Buy | 40,000 | $640,000 |
| 2025-01-24 | Keros Therapeutics, Inc. (KROS) | CHIEF FINANCIAL OFFICER | Sell | 40,000 | $1.8M |
Source: SEC Form 4 filings · as of 2026-02-20